Beth Israel Deaconess Medical Center
Clinical trials sponsored by Beth Israel Deaconess Medical Center, explained in plain language.
-
Microwave zapper for lung blockages fizzles out early
Disease control TerminatedThis study tested a new microwave device to clear blocked airways caused by cancer. Only 3 people took part before the study was stopped. The goal was to see if the tool could safely and effectively open the airway during a bronchoscopy.
Phase: NA • Sponsor: Beth Israel Deaconess Medical Center • Aim: Disease control
Last updated Jun 16, 2026 12:51 UTC
-
Promising HS drug trial halted early
Disease control TerminatedThis study tested a drug called deucravacitinib against a placebo for people with moderate-to-severe hidradenitis suppurativa (HS), a painful skin condition. The goal was to see if the drug could reduce inflammatory bumps and abscesses over 16 weeks. The trial was terminated earl…
Phase: PHASE2 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Disease control
Last updated Jun 15, 2026 18:56 UTC
-
Diarrhea drug trial halted early: what we know
Symptom relief TerminatedThis study tested whether crofelemer, a drug that reduces fluid secretion in the gut, could improve stool consistency in adults with functional diarrhea. The trial was terminated early after enrolling only 17 participants. The main goal was to measure stool firmness after 4 weeks…
Phase: PHASE4 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Symptom relief
Last updated Jun 15, 2026 19:05 UTC
-
Eye test may predict schizophrenia drug response, but study stalls
Symptom relief TerminatedThis study aimed to see if a retinal (eye) biomarker could predict how well people with early schizophrenia respond to sodium nitroprusside, an anti-inflammatory drug. It planned to enroll people diagnosed within the last 5 years, but was terminated after only 1 participant. The …
Phase: PHASE2 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Symptom relief
Last updated Jun 15, 2026 18:57 UTC
-
Migraine drug fremanezumab tested for sleep benefits – study halted early
Symptom relief TerminatedThis study looked at whether fremanezumab, an FDA-approved migraine prevention drug, could also improve sleep quality in people with migraines. Researchers planned to track 22 adults aged 18-65 with frequent migraines (10-25 headache days per month) over 4 months, comparing sleep…
Phase: PHASE4 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Symptom relief
Last updated Jun 01, 2026 17:57 UTC
-
Anesthesia drug study halted after just 3 patients
Knowledge-focused TerminatedThis study aimed to see if skipping a type of muscle relaxant during general anesthesia could lower the risk of serious lung complications in high-risk surgery patients. The trial was terminated early after enrolling only 3 participants, so no meaningful conclusions can be drawn.…
Phase: PHASE4 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:08 UTC
-
Tiny study explores better lung monitoring during surgery
Knowledge-focused TerminatedThis study looked at whether a special pressure measurement (esophageal pressure) can be used during surgeries where only one lung is ventilated. Six adults having non-cardiac surgery participated. Researchers compared the pressure readings to lung collapse images from a device c…
Sponsor: Beth Israel Deaconess Medical Center • Aim: Knowledge-focused
Last updated Jun 08, 2026 13:10 UTC
-
New device measures skin stiffness to track lymphedema
Knowledge-focused TerminatedThis study tested a noninvasive device that measures skin elasticity in people with lymphedema, a condition causing swelling. Researchers aimed to better understand how the disease progresses and how surgery affects it. Only 7 adults from one hospital took part, and the study was…
Phase: NA • Sponsor: Beth Israel Deaconess Medical Center • Aim: Knowledge-focused
Last updated Jun 05, 2026 12:07 UTC
-
New blood pressure cuff could replace needles for High-Risk C-Sections
Knowledge-focused TerminatedThis study tested a non-invasive blood pressure monitor (CNAP) against the standard invasive method (using a needle in the artery) in 20 pregnant women with placenta accreta undergoing scheduled C-sections. The goal was to see if the gentler method gives equally accurate readings…
Sponsor: Beth Israel Deaconess Medical Center • Aim: Knowledge-focused
Last updated May 22, 2026 13:53 UTC